Neoplasia (New York, N.Y.) - JoVE Visualize

Showing results (551-560 of 2,753) with videos related to

Pageof 276

Sort By:

Neoplasia (New York, N.Y.)|February 5, 2026

Identification of molecularly targeted therapy-induced immunopeptidome in diffuse midline glioma (DMG)Niloofar Khairkhah, Habeebah Owolabi, Ali Namvar, et al.

Neoplasia (New York, N.Y.)|January 7, 2026

Visceral adiposity as a metabolic risk factor for bone tumors: Insights from the NHANES population-based studyXianliang Wang, Rengcheng Qian, Zhenlang Lin, et al.

Neoplasia (New York, N.Y.)|January 7, 2026

THOC1 complexes with SIN3A to regulate R-loops and promote glioblastoma progressionShreya Budhiraja, Umme H Faisal, Shivani Baisiwala, et al.

Neoplasia (New York, N.Y.)|April 28, 2020

LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinaseDongdong Chen, Julie Cox, Jayabhargav Annam, et al.

Neoplasia (New York, N.Y.)|April 28, 2020

Transgenic expression of Sag/Rbx2 E3 causes early stage tumor promotion, late stage cytogenesis and acinar loss in the Kras-PDAC modelQiang Zhang, Dongping Wei, Mingjia Tan, et al.

Neoplasia (New York, N.Y.)|February 22, 2023

Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitorsYongkang Bai, Xiang Liu, Limin Zheng, et al.

Neoplasia (New York, N.Y.)|December 4, 2025

IFNβ-pSTAT1-IRF1 axis controls colorectal tumor development through induction of immunogenic Ly6C+myeloid cellsYan Li, Yanmin Wu, Liyan Liang, et al.

Neoplasia (New York, N.Y.)|October 26, 2012

Opposite roles of furin and PC5A in N-cadherin processingDeborah Maret, Mohamad Seyed Sadr, Emad Seyed Sadr, et al.

Neoplasia (New York, N.Y.)|October 26, 2012

STAT5b as molecular target in pancreatic cancer--inhibition of tumor growth, angiogenesis, and metastasesChristian Moser, Petra Ruemmele, Sebastian Gehmert, et al.

Neoplasia (New York, N.Y.)|October 26, 2012

Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapyLisa D Volk-Draper, Sandeep Rajput, Kelly L Hall, et al.

Pageof 276

Showing results (551-560 of 2,753) with videos related to

Sort By:

Pageof 276

Neoplasia (New York, N.Y.)|February 5, 2026

Identification of molecularly targeted therapy-induced immunopeptidome in diffuse midline glioma (DMG)Niloofar Khairkhah, Habeebah Owolabi, Ali Namvar, et al.

Neoplasia (New York, N.Y.)|January 7, 2026

Visceral adiposity as a metabolic risk factor for bone tumors: Insights from the NHANES population-based studyXianliang Wang, Rengcheng Qian, Zhenlang Lin, et al.

Neoplasia (New York, N.Y.)|January 7, 2026

THOC1 complexes with SIN3A to regulate R-loops and promote glioblastoma progressionShreya Budhiraja, Umme H Faisal, Shivani Baisiwala, et al.

Neoplasia (New York, N.Y.)|April 28, 2020

LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinaseDongdong Chen, Julie Cox, Jayabhargav Annam, et al.

Neoplasia (New York, N.Y.)|April 28, 2020

Transgenic expression of Sag/Rbx2 E3 causes early stage tumor promotion, late stage cytogenesis and acinar loss in the Kras-PDAC modelQiang Zhang, Dongping Wei, Mingjia Tan, et al.

Neoplasia (New York, N.Y.)|February 22, 2023

Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitorsYongkang Bai, Xiang Liu, Limin Zheng, et al.

Neoplasia (New York, N.Y.)|December 4, 2025

IFNβ-pSTAT1-IRF1 axis controls colorectal tumor development through induction of immunogenic Ly6C+myeloid cellsYan Li, Yanmin Wu, Liyan Liang, et al.

Neoplasia (New York, N.Y.)|October 26, 2012

Opposite roles of furin and PC5A in N-cadherin processingDeborah Maret, Mohamad Seyed Sadr, Emad Seyed Sadr, et al.

Neoplasia (New York, N.Y.)|October 26, 2012

STAT5b as molecular target in pancreatic cancer--inhibition of tumor growth, angiogenesis, and metastasesChristian Moser, Petra Ruemmele, Sebastian Gehmert, et al.

Neoplasia (New York, N.Y.)|October 26, 2012

Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapyLisa D Volk-Draper, Sandeep Rajput, Kelly L Hall, et al.

Pageof 276